China Finalizes Regulations for Pharmaceutical Sales Representatives

China’s 2026 Management Measures for Medical Representatives significantly expand pharmaceutical compliance obligations by imposing stricter oversight on medical representatives, Marketing…

Read the full article

Siyi Gu ([email protected])23d agoen

You might also wanna read

China creates new regulatory pathway to accelerate access to advanced biomedical therapies

The country’s new regulatory pathway promises to accelerate access to advanced therapies for Chinese patients, but may change the licensing

biopharmadive.com·26d ago

Alibaba probe unearthed evidence it knowingly let dangerous drugs be sold to U.S. consumers

For eight years, Chinese online retailer Alibaba and its U.S. payment processing company failed to prevent dangerous drugs, chemicals and pi

CBSNews·1d ago

Traitements contre le cancer : «La Chine est en train de devenir le leader mondial du médicament»

Les investissements de la Chine dans l’innovation et l’industrie pharmaceutique sont colossaux

l.liberation.fr·1mo ago

AstraZeneca compra a una farmacéutica de China los derechos de un medicamento pulmonar por 1.900 millones

Se trata de un inhibidor dual de PDE3/4 concebido para proporcionar efectos broncodilatadores y antiinflamatorios simultáneos.

20MINUTOS.ES·3d ago

The Indian Competition Authority reviews 15 years of enforcement and merger scrutiny in the pharmaceutical and life sciences sector, targeting trade association cartels, hospital excessive pricing and patent-related dominance concerns

The life sciences and pharmaceutical industry in India is of great significance globally as well as domestically, being the third largest (b

concurrences.com·3d ago